Clinical Trial Update: THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death [Phase 3]

View source ↗

Summary

Phase 3 THALES trial evaluating ticagrelor plus aspirin for prevention of stroke and death after acute ischemic stroke or transient ischemic attack; trial compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Aspirin (Aspirin)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Ischaemic Stroke, Transient Ischaemic Attack | Phase 3 | Status: COMPLETED | Results posted: 2020-12-22